- Home
- XXII vs GCTK Comparison
XXII vs GCTK Comparison
Compare XXII & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XXII
- GCTK
- Stock Information
- Founded
- XXII 1998
- GCTK 2001
- Country
- XXII United States
- GCTK United States
- Employees
- XXII N/A
- GCTK N/A
- Industry
- XXII Medicinal Chemicals and Botanical Products
- GCTK Medical/Dental Instruments
- Sector
- XXII Health Care
- GCTK Health Care
- Exchange
- XXII Nasdaq
- GCTK Nasdaq
- Market Cap
- XXII 6.2M
- GCTK 5.9M
- IPO Year
- XXII N/A
- GCTK N/A
- Fundamental
- Price
- XXII $0.88
- GCTK $5.09
- Analyst Decision
- XXII
- GCTK
- Analyst Count
- XXII 0
- GCTK 0
- Target Price
- XXII N/A
- GCTK N/A
- AVG Volume (30 Days)
- XXII 1.3M
- GCTK 29.9K
- Earning Date
- XXII 11-04-2025
- GCTK 11-13-2025
- Dividend Yield
- XXII N/A
- GCTK N/A
- EPS Growth
- XXII N/A
- GCTK N/A
- EPS
- XXII N/A
- GCTK N/A
- Revenue
- XXII $20,346,000.00
- GCTK N/A
- Revenue This Year
- XXII N/A
- GCTK N/A
- Revenue Next Year
- XXII $126.57
- GCTK N/A
- P/E Ratio
- XXII N/A
- GCTK N/A
- Revenue Growth
- XXII 16.98
- GCTK N/A
- 52 Week Low
- XXII $0.78
- GCTK $4.22
- 52 Week High
- XXII $336.89
- GCTK $468.00
- Technical
- Relative Strength Index (RSI)
- XXII 28.09
- GCTK 36.43
- Support Level
- XXII $0.84
- GCTK $4.80
- Resistance Level
- XXII $0.95
- GCTK $6.04
- Average True Range (ATR)
- XXII 0.10
- GCTK 0.25
- MACD
- XXII -0.03
- GCTK -0.06
- Stochastic Oscillator
- XXII 8.61
- GCTK 17.86
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.